For many organisations, carbon accounting has become a familiar exercise. Each year, emissions are measured, reports are compiled, and numbers are shared with stakeholders. These steps are valuable. They build transparency, accountability, and a foundation for progress. But as sustainability
The convergence of regulatory pressure, investor expectations, and technological innovation has elevated sustainability transformation and carbon accounting from a compliance exercise to a strategic imperative. With 98% of Fortune 100 companies committing to sustainability and the carbon accounting software market
CCS in the Climate Puzzle Carbon Capture and Storage (CCS) has shifted from being a niche technology to one of the most critical levers in global decarbonization strategies. As industries such as power generation, cement, steel, and chemicals wrestle with
Climate change has emerged as one of the most pressing global challenges of our time, with industries across the globe reevaluating their carbon footprints. For the pharmaceutical sector, particularly Active Pharmaceutical Ingredient (API) manufacturing, sustainability is no longer an option
low carbon building market report includes region like North America (U.S, Canada, Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, Netherlands, Turkey), Asia-Pacific (China, Japan, Malaysia, South Korea, India, Indonesia, Australia), South America (Brazil, Argentina), Middle-East (Saudi Arabia, UAE, Kuwait,